Recent literature proposes that amyloid-β and phosphorylated tau (p-tau) synergism accelerates biomarker abnormalities in controls. Yet, it remains to be answered whether this synergism is the driving force behind Alzheimer disease (AD) dementia.
from Dementia Big http://ift.tt/2hlj0KT via alcoholic dementia
http://ift.tt/2i4w474
No comments:
Post a Comment